COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 2 années 8 mois Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 2 années 8 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 2 années 10 mois Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 3 années 3 mois OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 3 années 5 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 3 années 5 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 3 années 5 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 3 années 5 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 3 années 6 mois Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 3 années 6 mois Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 12/10/2026 à 15:47, il y a 1 heure 50 minutes Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 30 septembre 2026
Publié le 12/10/2026 à 15:47, il y a 1 heure 50 minutes Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Publié le 12/10/2026 à 15:12, il y a 2 heures 25 minutes Statement of transactions in own shares from October 5, 2026 to October 9, 2026
Publié le 12/10/2026 à 15:12, il y a 2 heures 25 minutes Déclaration des transactions sur actions propres réalisées du 05/10/2026 au 09/10/2026
Publié le 12/10/2026 à 14:15, il y a 3 heures 22 minutes Guillemot Corporation S.A. | Weekly report share buyback from October 5 to October 9, 2026
Publié le 12/10/2026 à 15:00, il y a 2 heures 38 minutes Shelfie-Tech Announces Closing of Private Placement
Publié le 12/10/2026 à 13:00, il y a 4 heures 38 minutes U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Publié le 10/10/2026 à 04:45, il y a 2 jours 12 heures Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Publié le 10/10/2026 à 02:03, il y a 2 jours 15 heures BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Publié le 10/10/2026 à 02:00, il y a 2 jours 15 heures Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Publié le 12/10/2026 à 16:59, il y a 38 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 12/10/2026 à 16:55, il y a 43 minutes Afreximbank Barbados Country Brief spotlights market’s economic resilience and reform-driven path for growth
Publié le 12/10/2026 à 15:42, il y a 1 heure 56 minutes Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Publié le 12/10/2026 à 15:41, il y a 1 heure 56 minutes Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.